American for-profit health system HCA Healthcare has logged attributable net income of $1.59bn in the first quarter (Q1) of 2024, a 16.7% increase from $1.36bn in the same period last year.
The Tennessee-based company’s diluted earnings per share in the first three months of 2024 were $5.93, versus $4.85 a year ago.
Go deeper with GlobalData
Benefitting from strong patient volumes, the company’s revenues grew 11.2%, climbing to $17.34bn in Q1 2024 from $16.82bn in the prior year.
Its adjusted EBITDA for the quarter ending 31 March 2024 stood at $3.35bn, up from $3.17bn in Q1 2023.
The company said that its performance in this quarter included $201m of gains from facility sales.
HCA Healthcare witnessed a 6.2% year-on-year rise in same facility admissions, a 5.2% increase in same facility equivalent admissions, and a 7.2% rise in same facility emergency room visits.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataHowever, surgical procedures registered mixed performance, with same facility inpatient surgeries growing 1.7% and same facility outpatient surgeries dipping 2.1%.
Same facility revenue per equivalent admission in the January-March 2024 quarter was 3.5% higher than a year ago.
Capital expenditures for the first quarter, excluding acquisitions, amounted to $1.12bn. The company’s operating activities generated cash flows of $2.47bn, an increase from $1.8bn in the previous year.
At the end of this March, HCA Healthcare reported cash and cash equivalents of $1.28bn, total debt of $40.19bn and total assets of $56.96bn.
Besides, the health system announced a quarterly cash dividend of $0.66 per share and repurchased nearly 3.9 million shares of its common stock for $1.18bn, with $5.59bn remaining under its repurchase authorisation.
Commenting on the results, HCA Healthcare CEO Sam Hazen stated: “The strong fundamentals we saw in our business this past year continued into the first quarter of 2024. This momentum generated strong financial results that were driven primarily by broad-based volume growth.”
HCA Healthcare operates 188 hospitals and roughly 2,400 ambulatory sites of care across 20 states US and the UK.
